Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Dillon

Showing results (71-80 of 176) with videos related to

Pageof 18
Sort By:
The Journal of Applied Laboratory Medicine|September 11, 2020
Intelligent Liver Function Testing: Working Smarter to Improve Patient Outcomes in Liver DiseaseIain Macpherson, Jennifer H Nobes, Eleanor Dow, et al.
Gut|March 24, 2012
Spontaneous bacterial peritonitis prophylaxis in the era of healthcare associated infectionHasnain M Jafferbhoy, Michael H Miller, W Gashau, et al.
Molecular & Cellular Proteomics : MCP|February 18, 2004
The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damageElizabeth Pohler, Ashley L Craig, James Cotton, et al.
Journal of Gastroenterology and Hepatology|April 23, 2014
Serum proteome of nonalcoholic fatty liver disease: a multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitisMichael H Miller, Shaun V Walsh, Abdel Atrih, et al.
BMC Health Services Research|April 18, 2007
Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE)Peter T Donnan, David McLernon, Douglas Steinke, et al.
Frontline Gastroenterology|October 19, 2023
Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveysKushala W M Abeysekera, Ankur Srivastava, Ian Rowe, et al.
The International Journal on Drug Policy|May 18, 2010
Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infectionScott A McDonald, Sharon J Hutchinson, Sheila M Bird, et al.
Addiction (Abingdon, England)|September 20, 2023
A transient positive association between direct-acting antiviral therapy for hepatitis C infection and drug-related hospitalization among people who inject drugs: Self-controlled case-series analysis of national dataScott A McDonald, Matthew Hickman, John F Dillon, et al.
Plos One|December 29, 2012
The utility of liver function tests for mortality prediction within one year in primary care using the algorithm for liver function investigations (ALFI)David J McLernon, John F Dillon, Frank M Sullivan, et al.
BMJ Open|June 4, 2014
Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohortsDavid J McLernon, Peter T Donnan, Frank M Sullivan, et al.
Pageof 18

Showing results (71-80 of 176) with videos related to

Sort By:
Pageof 18
The Journal of Applied Laboratory Medicine|September 11, 2020
Intelligent Liver Function Testing: Working Smarter to Improve Patient Outcomes in Liver DiseaseIain Macpherson, Jennifer H Nobes, Eleanor Dow, et al.
Gut|March 24, 2012
Spontaneous bacterial peritonitis prophylaxis in the era of healthcare associated infectionHasnain M Jafferbhoy, Michael H Miller, W Gashau, et al.
Molecular & Cellular Proteomics : MCP|February 18, 2004
The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damageElizabeth Pohler, Ashley L Craig, James Cotton, et al.
Journal of Gastroenterology and Hepatology|April 23, 2014
Serum proteome of nonalcoholic fatty liver disease: a multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitisMichael H Miller, Shaun V Walsh, Abdel Atrih, et al.
BMC Health Services Research|April 18, 2007
Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE)Peter T Donnan, David McLernon, Douglas Steinke, et al.
Frontline Gastroenterology|October 19, 2023
Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveysKushala W M Abeysekera, Ankur Srivastava, Ian Rowe, et al.
The International Journal on Drug Policy|May 18, 2010
Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infectionScott A McDonald, Sharon J Hutchinson, Sheila M Bird, et al.
Addiction (Abingdon, England)|September 20, 2023
A transient positive association between direct-acting antiviral therapy for hepatitis C infection and drug-related hospitalization among people who inject drugs: Self-controlled case-series analysis of national dataScott A McDonald, Matthew Hickman, John F Dillon, et al.
Plos One|December 29, 2012
The utility of liver function tests for mortality prediction within one year in primary care using the algorithm for liver function investigations (ALFI)David J McLernon, John F Dillon, Frank M Sullivan, et al.
BMJ Open|June 4, 2014
Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohortsDavid J McLernon, Peter T Donnan, Frank M Sullivan, et al.
Pageof 18